Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

While serving as a representative of Florida in Congress, Weldon had raised concerns about the CDC controlling vaccines, believing they have a conflict of interest tied to “Big Pharma.” ...

Analysts have been steadily raising their estimates for Corbus Pharmaceuticals. Over the past three months, the Zacks Consensus Estimate for the company has increased 2.4%. Unlike the overly ...

Firefighters quickly put out the fire. No significant damage or injuries were reported. Putin says Russia in favor of ceasefire proposal, but 'there is a nuance' Lamar Jackson Puts 31 Teams on ...

Zealand's stock jump suggested it could be acquired by Roche, and Zealand has been seen as a possible target, one shareholder told Reuters on condition of anonymity. "We have always said our ...

In this article, we will look at the 11 Best Pharma Stocks to Buy According to ... According to CNBC, buyers have devised a business model allowing them to import medicines through licensing ...

Pharmaceutical giants such as J&J ... More than 56,000 of J&J's 138,000 workers have taken a generative AI training course, which is required before any employee is authorized to use the technology.

Sun Pharmaceutical Industries Limited on Monday announced that it will acquire Checkpoint, an immunotherapy and targeted oncology company. According to the company’s exchange filing, Checkpoint ...

could have put Wales in with a chance of beating the home side. After a conversation with TMO Eric Gauzins, referee Andrea Piardi decided to rule out the try, with Murray's jump over Will Hurd ...

Currently, Recursion Pharmaceuticals, Inc. does not have a price-earnings ratio. Recursion Pharmaceuticals, Inc.’s trailing 12-month revenue is $58.8 million with a -788.0% net profit margin.